Key Developments: Illumina Inc (ILMN.O)

ILMN.O on Nasdaq

220.07USD
2 Jul 2015
Change (% chg)

$-0.61 (-0.28%)
Prev Close
$220.68
Open
$222.16
Day's High
$222.20
Day's Low
$219.25
Volume
933,726
Avg. Vol
1,282,153
52-wk High
$223.38
52-wk Low
$145.12

Search Stocks

Latest Key Developments (Source: Significant Developments)

Illumina Merck KGaA, Darmstadt, Germany, and Genea form the global fertility alliance for excellence in Assisted Reproductive Treatment
Monday, 8 Jun 2015 07:00am EDT 

Illumina:Says formation of the Global Fertility Alliance, a new collaboration to advance excellence in fertility technologies and processes within the assisted reproductive treatment (ART) laboratory.Says alliance is a partnership between Illumina, Merck KGaA, Darmstadt, Germany, and Genea, which develops innovative fertility technologies.  Full Article

Illumina Inc files new patent infringement suit against Ariosa Diagnostics Inc and Roche Molecular Systems Inc
Monday, 18 May 2015 04:05pm EDT 

Illumina Inc:Files new patent infringement suit against Ariosa Diagnostics Inc and its parent company, Roche Molecular Systems Inc.Says it is seeking all available remedies.New suit, filed in U.S. District Court for Northern District of California, is based on Ariosa's infringement of U.S. patent no. 7,955,794.  Full Article

Illumina Inc raises FY 2015 EPS guidance
Tuesday, 21 Apr 2015 04:05pm EDT 

Illumina Inc:Expects FY 2015 revenue growth of 20pct.Expects increased FY 2015 non-GAAP EPS to be in the range of $3.36 to $3.42.FY 2015 EPS of $3.17 on revenue of $2.255 billion - Thomson Reuters I/B/E/S.  Full Article

Illumina, Inc files Patent Infringement Suit in United Kingdom against Premaitha Health plc for Infringement of NIPT Patents
Monday, 16 Mar 2015 04:05am EDT 

Illumina, Inc:Says that it and it's wholly-owned subsidiary, Verinata Health Inc, have filed patent infringement suit against Premaitha Health plc in High Court of Justice, Chancery Division, Patents Court in United Kingdom.Says patents asserted are European Patent (UK) 0 994 963 B2 and European Patent (UK) 1 981 995 B1, which are exclusively licensed to Illumina from Sequenom, Inc and board of Trustees of Leland Stanford Junior University, respectively.Patents are directed to using cell-free fetal DNA for non-invasive prenatal testing.Suit accuses Premaitha's IONA(reg) Test of infringement, including it's use of sequencing to analyze cell-free fetal DNA from a sample of maternal blood.  Full Article

Illumina Inc announces strategic collaboration with Merck KGaA's biopharmaceuticals business
Tuesday, 10 Mar 2015 09:00am EDT 

Illumina Inc:Has formed a collaboration with Merck Serono, the biopharmaceuticals business of Merck KGaA, to develop a universal sequencing (NGS)-based oncology diagnostic.In addition to separate collaborations with AstraZeneca, Janssen Biotech Inc, and Sanofi, Illumina and Merck Serono will work to create a universal test system for clinical trials of targeted cancer therapies, with the goal of a more comprehensive tool for precision medicine.  Full Article

Illumina Inc reaffirms FY 2015 guidance
Tuesday, 27 Jan 2015 04:05pm EST 

Illumina Inc:Projects about 20 pct FY 2015 revenue growth, assuming current currency exchange rates, and FY 2015 non-GAAP earnings per diluted share of $3.12 to $3.18.Reported revenue of $1.856 billion in FY 2014.FY 2015 revenue of $2.264 billion - Thomson Reuters I/B/E/S.  Full Article

Illumina Inc gives FY 2015 guidance; EPS guidance in line with analysts' estimates
Monday, 12 Jan 2015 02:00pm EST 

Illumina Inc:Expects FY 2015 revenue growth of 20pct.Expects FY 2015 non-GAAP EPS to be in the range of $3.12 to $3.18.FY 2015 EPS of $3.17 on revenue of $2.255 billion - Thomson Reuters I/B/E/S.  Full Article

Universities of Edinburgh and Glasgow are to partner with Illumina Inc
Sunday, 11 Jan 2015 07:00pm EST 

Illumina Inc:Says the Universities of Edinburgh and Glasgow are to partner with Illumina.The investment will establish The Scottish Genomes Partnership, which will install 15 HiSeq X sequencing instruments divided between two hubs within the Universities.  Full Article

Biomerieux agrees with Illumina to launch NGS epidemiology solution for service labs
Tuesday, 18 Nov 2014 01:00am EST 

Biomerieux SA:Signs exclusive agreement with Illumina to launch next-generation sequencing (NGS) epidemiology solution for service labs.Companies are to jointly develop applications for microbiology sequencing technologies within four-year renewable period.  Full Article

Illumina announces completion of IVD development and supply agreement with Illumina
Thursday, 30 Oct 2014 07:02am EDT 

Illumina Inc:Says HTG Molecular Diagnostics Inc enters into an agreement with the company under which HTG will have the right to develop certain in-vitro diagnostic (IVD) test kits that utilize Illumina sequencing technology.  Full Article

BRIEF-Merck Serono, Illumina to collaborate on cancer diagnostics

* Merck Serono and Illumina enter strategic collaboration for diagnostics in oncology

Search Stocks